|
|
 |
Children with disabilities differin gel prospect in romana The plan to purchase Bever Pharmaceutical prompted a sell-off in Pharmstandard's shares when it was first announced in July. Analysts were concerned about a lack of information regarding Bever or a clear reason for the deal. Pharmstandard shares are trading 25 percent below their price prior to the deal's announcement.
2021-4-26 3:37:48 |
|
|
|
